➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
AstraZeneca
Harvard Business School
Mallinckrodt
Moodys

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Patent: 9,956,192

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 9,956,192
Title:Selective histone deactylase 6 inhibitors
Abstract: Disclosed are selective histone deactylase inhibitors (HDACi) that having Formula (I). Methods of making and using these inhibitors for the treatment of cancer, in particular melanoma are also disclosed. ##STR00001##
Inventor(s): Sotomayor; Eduardo M. (Tampa, FL), Bergman; Joel (Chicago, IL), Kozikowski; Alan (Chicago, IL), Woan; Karrune Veeraprasert (Gainesville, FL), Villagra; Alejandro V. (Tampa, FL)
Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL) Board of Trustees of The University of Illinois (Urbana, IL)
Application Number:15/231,187
Patent Claims:see list of patent claims

Details for Patent 9,956,192

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb YERVOY ipilimumab INJECTABLE; INJECTION 125377 2011-03-25 ⤷  Free Forever Trial H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL) Board of Trustees of The University of Illinois (Urbana, IL) 2032-03-07 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 9,956,192

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2013134467 ⤷  Free Forever Trial
United States of America 2015056213 ⤷  Free Forever Trial
United States of America 2017035710 ⤷  Free Forever Trial
United States of America 9409858 ⤷  Free Forever Trial
Japan 2015510886 ⤷  Free Forever Trial
Japan 6233812 ⤷  Free Forever Trial
European Patent Office 2822926 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Mallinckrodt
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.